Check out your Company Bowl for anonymous work chats.
What does a company need to be innovative? Read the interview to find out why our Head of Research and CTO Oscar-Werner Reif believes that the crucial factor is the people, not the money – and how he wins over talented people to work for Sartorius.
Sartorius is expanding its manufacturing capabilities in Israel. Today, we opened a new 11,800-square-foot production facility in Beit Haemek and the upgraded facility already in place. The new site enables the production of advanced cell culture media, particularly for the advanced therapies market. Watch the guided tour of the facility and meet our Beit Haemek team.
Sartorius is expanding its production capabilities in Slovenia. The expanded site in Ajdovscina will contribute to the development and #manufacturing of market-leading products for #purification and analysis of large biomolecules, such as viruses, plasmids and #mRNA. These are used in vaccines as well as in cell and gene therapies and other advanced therapies.
The biopharmaceutical market is growing dynamically - and so is Sartorius. This development continuously provides new #jobs and #opportunities for those who seize them: In 2020 alone, we have created more than 1,600 jobs and welcomed more than 2,500 new colleagues. Find out more about people at Sartorius: https://bit.ly/3tRCnvD
The biopharmaceutical market is growing dynamically - and so is Sartorius. This development continuously provides new #jobs and #opportunities for those who seize them: In 2020 alone, we have created more than 1,600 jobs and welcomed more than 2,500 new colleagues. Find out more about people at Sartorius: https://bit.ly/3tRCnvD
Women in leadership positions are a self-evident fact at Sartorius. We develop our employees in all areas, from HR to marketing and sales to R&D, and encourage them to actively advance their careers. Today, 38% of our managers directly below the board level are female. Learn more about diversity at Sartorius: https://bit.ly/3tRCnvD
The year 1990 marked a turning point in Sartorius' corporate history: The company, which had been family-run until then, went public. Along with a new strategic focus on life science research and the biopharmaceutical industry, this pointed the way to the future – and ultimately led to a sustained positive development.
Sartorius is expanding its production facilities in Ajdovscina, Slovenia: The area for manufacturing and labs will increase from 3,000 square meters to 6,200 square meters. Today’s ribbon cutting was attended by the Prime Minister of the Republic of Slovenia, Janez Janša. Read more: https://bit.ly/3fPIStH
How can companies solve complex scientific problems in today’s #lifescience and #biotechnology industry? For our Head of Corporate Research, Oscar-Werner Reif, the answer is clear: By fostering #partnership and #collaboration with leading experts. In this interview, he explains how Sartorius is driving #innovation - together with customers, universities, start-ups, companies, or in initiatives like NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals. Learn more about Sartorius’ collaborative approach: http://ow.ly/oeow50ERdjI
At Sartorius, innovative solutions for our customers are created as a team: For example, when long-standing employees combine their experience with the fresh ideas of new colleagues — a healthy mix of "old hands" and newcomers makes this possible. Find out more about #diversity at Sartorius: https://bit.ly/3tRCnvD
